BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 31136238)

  • 41. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fundamental frequency as a perceptual cue for vowel identification in speakers with Parkinson's disease.
    Bunton K
    Folia Phoniatr Logop; 2006; 58(5):323-39. PubMed ID: 16966834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
    Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
    Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting Intelligibility Deficits in Parkinson's Disease With Perceptual Speech Ratings.
    Chiu YF; Neel A
    J Speech Lang Hear Res; 2020 Feb; 63(2):433-443. PubMed ID: 32097080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes to articulatory kinematics in response to loudness cues in individuals with Parkinson's disease.
    Darling M; Huber JE
    J Speech Lang Hear Res; 2011 Oct; 54(5):1247-59. PubMed ID: 21386044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perception of coarticulatory information in normal speech and dysarthria.
    Tjaden K; Sussman J
    J Speech Lang Hear Res; 2006 Aug; 49(4):888-902. PubMed ID: 16908883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of SPEAK OUT! & LOUD Crowd on Functional Speech Measures in Parkinson's Disease.
    Sullivan L; Martin E; Allison KM
    Am J Speech Lang Pathol; 2024 Jul; 33(4):1930-1951. PubMed ID: 38838243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing Vowel Centralization in Dysarthria: A Comparison of Methods.
    Fletcher AR; McAuliffe MJ; Lansford KL; Liss JM
    J Speech Lang Hear Res; 2017 Feb; 60(2):341-354. PubMed ID: 28124069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling listener perception of speaker similarity in dysarthria.
    Lansford KL; Berisha V; Utianski RL
    J Acoust Soc Am; 2016 Jun; 139(6):EL209. PubMed ID: 27369174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Articulatory-acoustic vowel space: application to clear speech in individuals with Parkinson's disease.
    Whitfield JA; Goberman AM
    J Commun Disord; 2014; 51():19-28. PubMed ID: 25074511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of speaking rate manipulations on acoustic and perceptual aspects of the dysarthria in amyotrophic lateral sclerosis.
    Weismer G; Laures JS; Jeng JY; Kent RD; Kent JF
    Folia Phoniatr Logop; 2000; 52(5):201-19. PubMed ID: 10965174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating Acoustic Correlates of Intelligibility Gains and Losses During Slowed Speech: A Hybridization Approach.
    van Brenk F; Kain A; Tjaden K
    Am J Speech Lang Pathol; 2021 Jun; 30(3S):1343-1360. PubMed ID: 34048663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences between Subjective and Objective Assessment of Speech Deficiency in Parkinson Disease.
    Pawlukowska W; Szylińska A; Kotlęga D; Rotter I; Nowacki P
    J Voice; 2018 Nov; 32(6):715-722. PubMed ID: 29122413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Speech and pause characteristics associated with voluntary rate reduction in Parkinson's disease and Multiple Sclerosis.
    Tjaden K; Wilding G
    J Commun Disord; 2011; 44(6):655-65. PubMed ID: 21767851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sentence-Level Movements in Parkinson's Disease: Loud, Clear, and Slow Speech.
    Kearney E; Giles R; Haworth B; Faloutsos P; Baljko M; Yunusova Y
    J Speech Lang Hear Res; 2017 Dec; 60(12):3426-3440. PubMed ID: 29209727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of speaking task on intelligibility in Parkinson's disease.
    Tjaden K; Wilding G
    Clin Linguist Phon; 2011 Feb; 25(2):155-68. PubMed ID: 20887216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prominence marking in parkinsonian speech and its correlation with motor performance and cognitive abilities.
    Thies T; Mücke D; Lowit A; Kalbe E; Steffen J; Barbe MT
    Neuropsychologia; 2020 Feb; 137():107306. PubMed ID: 31857118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.
    Körner Gustafsson J; Södersten M; Ternström S; Schalling E
    Logoped Phoniatr Vocol; 2019 Oct; 44(3):124-133. PubMed ID: 29447488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intelligibility of dysarthric speech: perceptions of speakers and listeners.
    Walshe M; Miller N; Leahy M; Murray A
    Int J Lang Commun Disord; 2008; 43(6):633-48. PubMed ID: 18608608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acoustic properties of vowel production in Mandarin-speaking patients with post-stroke dysarthria.
    Mou Z; Chen Z; Yang J; Xu L
    Sci Rep; 2018 Sep; 8(1):14188. PubMed ID: 30242251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.